JC

Jason Carroll

Tryptamine Therapeutics Limited | Non-Executive Director
--

Company and Role

Company
Title
Tenure
Since
TYP
Tryptamine Therapeutics Limited
  • Non-Executive Director
2mthMay 2024

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
TYP
Tryptamine Therapeutics Limited
14/06/2436,750,000N/A47,892,190N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
TYP
Tryptamine Therapeutics Limited
14/06/24
Buy
604,738$0.020$11,990On-market trade
TYP
Tryptamine Therapeutics Limited
06/06/24
Buy
1,692,514$0.021$36,090On-market trade
TYP
Tryptamine Therapeutics Limited
05/06/24
Buy
952,748$0.022$20,960On-market trade
TYP
Tryptamine Therapeutics Limited
03/06/24
Buy
1,000,000$0.025$25,000On-market trade
TYP
Tryptamine Therapeutics Limited
30/05/24
Buy
500,000$0.024$12,000On-market trade